{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:39:25Z","timestamp":1790969965867,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Pancreatol"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf02788354","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T09:54:47Z","timestamp":1628589287000},"page":"15-21","source":"Crossref","is-referenced-by-count":64,"title":["Overexpression of HER2\/neu oncogene in pancreatic cancer correlates with shortened survival"],"prefix":"10.1007","volume":"17","author":[{"given":"Shize","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert E.","family":"Appert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunzo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don R.","family":"Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitai","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02788354_CR1","volume-title":"Cancer Facts and Figures\u20141991","author":"American Cancer Society","year":"1991","unstructured":"American Cancer Society.Cancer Facts and Figures\u20141991. The American Cancer Society, Inc., Atlanta, GA, 1991."},{"key":"BF02788354_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jso.2930100602","volume":"10","author":"AL Cubilla","year":"1978","unstructured":"Cubilla AL, Fitzgerald PJ, Fortner JG. Pancreas cancerduct cell adenocarcinoma: survival in relation to site, size, stage, and type of therapy.J Surg Oncol 1978; 10: 465\u2013487.","journal-title":"J Surg Oncol"},{"key":"BF02788354_CR3","first-page":"28","volume":"97","author":"M Trede","year":"1985","unstructured":"Trede M. The surgical treatment of pancreatic carcinoma.Surgery 1985; 97: 28\u201335","journal-title":"Surgery"},{"key":"BF02788354_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00000658-198910000-00015","volume":"210","author":"F Michelassi","year":"1989","unstructured":"Michelassi F, Erroi F, Dawson PJ, Pietrabissa A, Noda S, Handcock M, Block GE. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas and distal common bile duct.Ann Surg 1989; 210: 544\u2013554.","journal-title":"Ann Surg"},{"key":"BF02788354_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0002-9610(86)90024-3","volume":"151","author":"PA Grace","year":"1986","unstructured":"Grace PA, Pitt HA, Tompkins PK, et al. Decreased morbidity and mortality after pancreatoduodenectomy.Am J Surg 1986; 151: 141\u2013149.","journal-title":"Am J Surg"},{"key":"BF02788354_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/00000658-198709000-00014","volume":"206","author":"DW Crist","year":"1987","unstructured":"Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure.Ann Surg 1987; 206: 358\u2013365.","journal-title":"Ann Surg"},{"key":"BF02788354_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00000658-198811000-00001","volume":"208","author":"AL Warshaw","year":"1988","unstructured":"Warshaw AL, Swanson RS. Pancreas cancer in 1988; possibilities and probabilities.Ann Surg 1988; 208: 541\u2013553.","journal-title":"Ann Surg"},{"key":"BF02788354_CR8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archsurg.1989.01410070028006","volume":"124","author":"CA Pellegrini","year":"1989","unstructured":"Pellegrini CA, Heck CF, Raper S, Way LW. An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy.Arch Surg 1989; 124: 778\u2013781.","journal-title":"Arch Surg"},{"key":"BF02788354_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-4731(89)90072-1","volume":"34","author":"AL Harris","year":"1989","unstructured":"Harris AL, Nicholson S, Sainsbury JR, Farndon J, Wright C. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions withneu.J Steroid Biochem 1989; 34: 123\u2013131.","journal-title":"J Steroid Biochem"},{"key":"BF02788354_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1990.8.1.103","volume":"8","author":"S Paik","year":"1990","unstructured":"Paik S, Hazan R, Fisher ER, DenBesten L, Longmire WP Jr. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projectaprognostic significance oferbB-2 protein overexpression in primary breast cancer.J Clin Oncol 1990; 8: 103\u2013112","journal-title":"J Clin Oncol"},{"key":"BF02788354_CR11","first-page":"555","volume":"51","author":"MC Paterson","year":"1991","unstructured":"Paterson MC, Dietrich KD, Danynuk J. Correlation between c-erbB-2 amplification and risk of recurrent disease in nodenegative breast cancer.Cancer Res 1991; 51: 555\u2013567.","journal-title":"Cancer Res"},{"key":"BF02788354_CR12","first-page":"5184","volume":"50","author":"JA Kern","year":"1990","unstructured":"Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. p185neuexpression in human lung adenocarcinomas predicts shortened survival.Cancer Res 1990; 50: 5184\u20135191.","journal-title":"Cancer Res"},{"key":"BF02788354_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/path.1711610305","volume":"161","author":"PA Hall","year":"1990","unstructured":"Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR. The c-erbB-2 proto-oncogene in human pancreatic cancer.J Pathol 1990; 161: 195\u2013200.","journal-title":"J Pathol"},{"key":"BF02788354_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/0046-8177(93)90194-L","volume":"24","author":"Y Yamanaka","year":"1993","unstructured":"Yamanaka Y, Friess H, Kobrin MS, Buchler M, et al. Overexpression of HER-2\/neu oncogene in human pancreatic carcinoma.Human Pathol 1993; 24: 1127\u20131134.","journal-title":"Human Pathol"},{"key":"BF02788354_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1272\/jnms1923.59.51","volume":"59","author":"Y Yamanaka","year":"1992","unstructured":"Yamanaka Y. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.J Nippon Med Sch 1992; 59: 51\u201361.","journal-title":"J Nippon Med Sch"},{"key":"BF02788354_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000163614","volume":"59","author":"TM Williams","year":"1991","unstructured":"Williams TM, Weiner DB, Greene MI, Maguire HC. Expression of c-erbB-2 in human pancreatic adenocarcinomas.Pathobiology 1991; 59: 46\u201352.","journal-title":"Pathobiology"},{"key":"BF02788354_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedure.J Histochem Cytochem 1981; 29: 577\u2013580.","journal-title":"J Histochem Cytochem"},{"key":"BF02788354_CR18","first-page":"511","volume":"38","author":"EL Kaplan","year":"1984","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observation.Am Stat Assoc 1984; 38: 511.","journal-title":"Am Stat Assoc"},{"key":"BF02788354_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/319226a0","volume":"319","author":"CI Bargmann","year":"1986","unstructured":"Bargmann CI, Hung MC, Weinberg RA. Theneu oncogene encodes an epidermal growth factor receptor-related protein.Nature (London) 1986; 319: 226\u2013229.","journal-title":"Nature (London)"},{"key":"BF02788354_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.256.5060.1205","volume":"256","author":"WE Holmes","year":"1992","unstructured":"Holmes WE, Sliwkouski MX, Akita RW, et al. Identification of heregulin, a specific activator of p185\n                              erbB2.Science 1992, 256: 1205\u20131210.","journal-title":"Science"},{"key":"BF02788354_CR21","first-page":"4087","volume":"50","author":"A Berchuck","year":"1990","unstructured":"Berchuck A, Kemel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, et al. Overexpression of HER-2\/neu is associated with poor survival in advanced epithelial ovarian cancer.Cancer Res 1990; 50: 4087\u20134091.","journal-title":"Cancer Res"},{"key":"BF02788354_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene.Science (Wash, DC) 1987;235: 177\u2013182.","journal-title":"Science (Wash, DC)"},{"key":"BF02788354_CR23","first-page":"2087","volume":"49","author":"C Wright","year":"1989","unstructured":"Wright C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.Cancer Res 1989; 49: 2087\u20132090.","journal-title":"Cancer Res"},{"key":"BF02788354_CR24","first-page":"471","volume":"29","author":"FL Tyson","year":"1988","unstructured":"Tyson FL, Soper JT, Daly L, et al. Overexpression and amplification of the c-erbB-2 (HER2\/neu) proto-oncogene in epithelial ovarian tumors and cell lines.Proc Am Assoc Cancer Res 1988; 29: 471.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF02788354_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, et al. Studies of HER-2\/neu proto-oncogene in human breast and ovarian cancer.Science (Wash, DC) 1989; 244: 707\u2013712.","journal-title":"Science (Wash, DC)"},{"key":"BF02788354_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02924229","volume":"7","author":"TM Wido","year":"1990","unstructured":"Wido TM, Myles JL, Pisharodi L, Sawyer T, Kim K, Gohara AF, Howard JM. Aneuploid DNA content in pancreatic adenocarcinoma.Int. J. Pancreatol. 1990; 7: 129\u2013134.","journal-title":"Int. J. Pancreatol."},{"key":"BF02788354_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00000658-199112000-00002","volume":"214","author":"DC Allison","year":"1991","unstructured":"Allison DC, Bose KK, Hruban RH, Piantadosi S, Dooley WC, Boitnott JK, Cameron JL. Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy.Ann Surg 1991; 214: 648\u2013656.","journal-title":"Ann Surg"},{"key":"BF02788354_CR28","first-page":"164","volume":"114","author":"SS Bacus","year":"1990","unstructured":"Bacus SS, Bacus JW, Slamon DJ, Press MF. HER-2\/neu oncogene expression and DNA ploidy analysis in breast cancer.Arch Pathol Lab Med 1990; 114: 164\u2013169.","journal-title":"Arch Pathol Lab Med"}],"container-title":["International journal of pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02788354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02788354\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02788354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T11:23:16Z","timestamp":1657192996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02788354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF02788354"],"URL":"https:\/\/doi.org\/10.1007\/bf02788354","relation":{},"ISSN":["0169-4197","2363-5134"],"issn-type":[{"value":"0169-4197","type":"print"},{"value":"2363-5134","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}